MedTrace Logo

Clinical Validation of the Point-of-Care MSD Influenza Test

NCT00863343 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 391

Last updated 2012-03-01

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate the performance of the MSD® Influenza Test in detecting influenza A and influenza B in subjects presenting with influenza-like-illness (ILI).

Conditions

  • Influenza Human

Interventions

BIOLOGICAL

Public Health Notification

For any H5 positive results, notification of the result to the site's local public health authorities.

Sponsors & Collaborators

Principal Investigators

  • Jacqueline Perodin, PhD, CCRP · Meso Scale Diagnostics

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-07-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00863343 on ClinicalTrials.gov